4594 — BrightPath Biotherapeutics Co Share News
0.000.00%
Table: Brightpath Biotherapeutics -2021/22 parent forecast
Table: Brightpath Biotherapeutics -2021/22 parent forecast
Table: Brightpath Biotherapeutics - 9-MTH parent results
Table: Brightpath Biotherapeutics - 6-MTH parent results
Table: Brightpath Biotherapeutics - Q1 parent results
Table: Brightpath Biotherapeutics -2020/21 parent results
Table: Brightpath Biotherapeutics - 9-MTH parent results
Table: Brightpath Biotherapeutics - 6-MTH parent results
Table: Brightpath Biotherapeutics - Q1 parent results
Table: Brightpath Biotherapeutics -2019/20 parent results
Table: Brightpath Biotherapeutics - 9-MTH parent results
Table: Brightpath Biotherapeutics -2019/20 parent forecast
Table: Brightpath Biotherapeutics - 6-MTH parent results
Table: Brightpath Biotherapeutics - Q1 parent results
Table: Brightpath Biotherapeutics -2018/19 parent results
Table: Brightpath Biotherapeutics -2018/19 parent forecast
Table: Brightpath Biotherapeutics - 9-MTH group results
Table: Brightpath Biotherapeutics - 6-MTH group results
Table: Brightpath Biotherapeutics -Q1 group results